North America Respiratory Syncytial Virus Diagnostics Market Size & Outlook
- Clinical Diagnostics
- In Vitro Diagnostics
- respiratory syncytial virus diagnostics market
- In Vitro Diagnostics
North America Respiratory Syncytial Virus Diagnostics Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask Prism AI anything about the respiratory syncytial virus diagnostics market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
North America respiratory syncytial virus diagnostics market highlights
- The North America respiratory syncytial virus diagnostics market generated a revenue of USD 2,583.1 million in 2024.
- The market is expected to grow at a CAGR of 5.4% from 2025 to 2030.
- In terms of segment, chromatographic immunoassay was the largest revenue generating product in 2024.
- Gel Microdroplets is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Canada is expected to register the highest CAGR from 2025 to 2030.
North America data book summary
| Market revenue in 2024 | USD 2,583.1 million |
| Market revenue in 2030 | USD 3,501.2 million |
| Growth rate | 5.4% (CAGR from 2025 to 2030) |
| Largest segment | Chromatographic immunoassay |
| Fastest growing segment | Gel Microdroplets |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Direct Fluorescent Antibody (DFA) Method, Rapid Antigen Diagnostic Test (RADTs), Molecular Diagnostics, Diagnostic Imaging, Gel Microdroplets, Flow Cytometry, Chromatographic Immunoassay |
| Key market players worldwide | Becton Dickinson & Co, Novartis AG ADR, Abbott Laboratories, QuidelOrtho Corp, Thermo Fisher Scientific Inc, Bio-Rad Laboratories Inc, Roche Holding AG ADR, BioMerieux SA, Diasorin SpA, Merck KGaA, Avacta Group PLC, Siemens Healthineers AG ADR, Quest Diagnostics Inc |
Other key industry trends
- In terms of revenue, North America region accounted for 41.2% of the global respiratory syncytial virus diagnostics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,957.2 million by 2030.
North America dominated the market with largest revenue share of 41.18% in 2024. The dominance of the region is attributed to the advanced healthcare infrastructure, high adoption of cutting-edge diagnostic technologies, and significant government and private sector investments in healthcare.
Moreover, increasing awareness of the severity of RSV infections, especially in high-risk populations such as infants and the elderly, has led to greater demand for early detection tools, fueling market growth. The growing emphasis on preventive healthcare and the shift toward patient-centric care further contribute to the rising adoption of RSV diagnostics.
No credit card required*
Publish Date: Jan 16, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Respiratory Syncytial Virus Diagnostics Market
Respiratory Syncytial Virus Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Novartis AG ADR | View profile | 76,057 | Lichtstrasse 35, Basel, Switzerland, 4056 | www.novartis.com |
| Roche Holding AG ADR | View profile | 103,605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | www.roche.com |
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Becton Dickinson & Co | View profile | 73,000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | www.bd.com |
| BioMerieux SA | View profile | 13,982 | Marcy l’Etoile, Lyon, France, 69280 | www.biomerieux.com |
| Siemens Healthineers AG ADR | View profile | 71,400 | Siemensstr. 3, Forchheim, BY, Germany, 91301 | www.siemens-healthineers.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Quest Diagnostics Inc | View profile | 48,000 | 500 Plaza Drive, Secaucus, NJ, United States, 07094 | www.questdiagnostics.com |
| QuidelOrtho Corp | View profile | 7,100 | 9975 Summers Ridge Road, San Diego, CA, United States, 92121 | www.quidelortho.com |
North America respiratory syncytial virus diagnostics market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Respiratory Syncytial Virus Diagnostics Market Outlook will help companies and investors design strategic landscapes.
Chromatographic Immunoassay was the largest segment with a revenue share of 28.9% in 2024.
Horizon Databook has segmented the North America respiratory syncytial virus diagnostics market based on direct fluorescent antibody (dfa) method, rapid antigen diagnostic test (radts), molecular diagnostics, diagnostic imaging, gel microdroplets, flow cytometry, chromatographic immunoassay covering the revenue growth of each sub-segment from 2018 to 2030.
North America dominated the market with largest revenue share of 41.18% in 2024. The dominance of the region is attributed to the advanced healthcare infrastructure, high adoption of cutting-edge diagnostic technologies, and significant government and private sector investments in healthcare.
Moreover, increasing awareness of the severity of RSV infections, especially in high-risk populations such as infants and the elderly, has led to greater demand for early detection tools, fueling market growth. The growing emphasis on preventive healthcare and the shift toward patient-centric care further contribute to the rising adoption of RSV diagnostics.
- North America Respiratory Syncytial Virus Diagnostics Market Product Outlook (Revenue, USD Million , 2018-2030)
- Direct Fluorescent Antibody (DFA) Method
- Rapid Antigen Diagnostic Test (RADTs)
- Molecular Diagnostics
- Diagnostic Imaging
- Gel Microdroplets
- Flow Cytometry
- Others
- Chromatographic Immunoassay
- North America Respiratory Syncytial Virus Diagnostics Market End Use Outlook (Revenue, USD Million , 2018-2030)
- Hospitals
- Laboratory
- Clinics
- Homecare
Reasons to subscribe to respiratory syncytial virus diagnostics market databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of respiratory syncytial virus diagnostics market databook
- Our clientele includes a mix of respiratory syncytial virus diagnostics market companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America respiratory syncytial virus diagnostics market, including forecasts for subscribers. This continent databook contains high-level insights into North America respiratory syncytial virus diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
North America Respiratory Syncytial Virus Diagnostics Market, 2018-2030 (US$M)
North America respiratory syncytial virus diagnostics market statistics, by product, 2018-2030 (US$M)
